Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Lyles

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Clinical Therapeutics|November 29, 2007
The prescribing continuum: between prescription and over-the-counter drugsAlan Lyles
Clinical Therapeutics|March 1, 2011
The importance of context to the generalizability of international research: the other health care reformAlan Lyles
Pharmacoeconomics|February 18, 2017
Pharmacy Benefit Management Companies: Do They Create Value in the US Healthcare System?Alan Lyles
Clinical Therapeutics|May 10, 2005
Must an interest be a conflict?Alan Lyles
Clinical Therapeutics|September 20, 2006
The reference case ten years later: has comparing cost-effectiveness analyses improved?Alan Lyles
Clinical Therapeutics|February 24, 2006
Creating alternative incentives for pharmaceutical innovationAlan Lyles
Population Health Management|December 30, 2009
Improving long-term weight management: social capital and missed opportunitiesAlan Lyles
Clinical Therapeutics|November 18, 2005
Public-private arrangements in disaster relief and recoveryAlan Lyles
Clinical Therapeutics|May 3, 2007
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureusAlan Lyles
Clinical Therapeutics|April 28, 2004
Public policy, private insurance benefits, and weight controlAlan Lyles
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Clinical Therapeutics|November 29, 2007
The prescribing continuum: between prescription and over-the-counter drugsAlan Lyles
Clinical Therapeutics|March 1, 2011
The importance of context to the generalizability of international research: the other health care reformAlan Lyles
Pharmacoeconomics|February 18, 2017
Pharmacy Benefit Management Companies: Do They Create Value in the US Healthcare System?Alan Lyles
Clinical Therapeutics|May 10, 2005
Must an interest be a conflict?Alan Lyles
Clinical Therapeutics|September 20, 2006
The reference case ten years later: has comparing cost-effectiveness analyses improved?Alan Lyles
Clinical Therapeutics|February 24, 2006
Creating alternative incentives for pharmaceutical innovationAlan Lyles
Population Health Management|December 30, 2009
Improving long-term weight management: social capital and missed opportunitiesAlan Lyles
Clinical Therapeutics|November 18, 2005
Public-private arrangements in disaster relief and recoveryAlan Lyles
Clinical Therapeutics|May 3, 2007
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureusAlan Lyles
Clinical Therapeutics|April 28, 2004
Public policy, private insurance benefits, and weight controlAlan Lyles
Pageof 7